drugset / Trial / NCT06004960

A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants

NCT06004960

Phase 1 Completed 6 enrolled Amgen
NaSingle-groupOpen-labelBasic science

Summary

The primary objective of this study is to perform mass balance following a single oral dose of \[14C\]CCX168 in healthy adult male participants.

Timeline

Start
2014-10-20
Primary completion
2014-12-05
Completion
2014-12-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Avacopan Small molecule 100 mg Oral